Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Generic equivalents: issues and concerns.

Journal of Clinical Pharmacology

|May 1, 1986

Summary

This summary is machine-generated.

Critical questions persist regarding the identification of bioequivalent and therapeutically equivalent drugs. Scientists, clinicians, and the FDA must urgently address these issues to ensure drug safety and efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diabetic patient compliance as a function of counseling. 1979.

The Annals of pharmacotherapy·2006

Same author

Avoiding polypharmacy and iatrogenesis in the nursing home.

Maryland medical journal (Baltimore, Md. : 1985)·1994

Same author

Understanding and managing Alzheimer's disease.

The Journal of practical nursing·1993

Same author

Institutionalisation and drug use in older adults in the US.

Drugs & aging·1993

Same author

Drug prescribing for the elderly.

Archives of family medicine·1993

Same author

Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Drugs & aging·1991

Same journal

AI is Excellent at the Discovery and Identification of Unrecognized Scientific Knowledge but There Is No Evidence That AI Can Create New Scientific Knowledge.

Journal of clinical pharmacology·2026

Same journal

Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA-Related Mechanisms.

Journal of clinical pharmacology·2026

Same journal

Flip-Flop Pharmacokinetics in Pregnancy and the Future of Obstetric Pharmacology.

Journal of clinical pharmacology·2026

Same journal

Correction to "A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants With End-Stage Kidney Disease on Hemodialysis".

Journal of clinical pharmacology·2026

Same journal

Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine-Naloxone With a Focus on the Unhoused Population.

Journal of clinical pharmacology·2026

Same journal

Ontology-Enhanced Deep Learning for Mechanistic Prediction of Drug-Drug Interactions: A Clinically Interpretable Framework.

Journal of clinical pharmacology·2026

See all related articles

Area of Science:

Pharmacology
Drug Development
Regulatory Science

Background:

Ensuring bioequivalence and therapeutic equivalence is crucial for drug safety and efficacy.
Current methodologies and criteria for establishing drug equivalence face ongoing scrutiny.

Purpose of the Study:

To highlight critical unresolved questions in the identification of bioequivalent and therapeutically equivalent drugs.
To emphasize the need for collaborative efforts to address these issues.

Main Methods:

This study is a critical review and discussion of existing challenges.
It synthesizes current understanding and identifies knowledge gaps.

Main Results:

Significant questions remain regarding the precise identification of bioequivalent and therapeutically equivalent drugs.

Related Experiment Videos

Existing frameworks may require refinement to fully address all relevant factors.

Conclusions:

Urgent attention is required from scientists, clinicians, and regulatory bodies like the FDA.
Addressing these critical questions is essential for advancing pharmaceutical science and public health.